Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma

Cancer Letters

Volumn 264, Issue 1, 2008, Pages 36-43

  Nishio, Shin ^a   Ushijima, Kimio ^a   Tsuda, Naotake ^a   Takemoto, Shuji ^a   Kawano, Kouichiro ^a   Yamaguchi, Tomohiko ^b   Nishida, Naoyo ^a,b   Kakuma, Tatsuyuki ^c   Tsuda, Hitoshi ^d   Kasamatsu, Takahiro ^e   Sasajima, Yuko ^e   Kage, Masayoshi ^b   Kuwano, Michihiko ^c   Kamura, Toshiharu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY HOSPITAL   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Angiogenesis; Cap43; Cervical adenocarcinoma; Prognosis

Indexed keywords

VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CAP43 GENE; CONTROLLED STUDY; DIFFERENTIATION RELATED GENE 1; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; N MYC DOWNSTREAM REGULATED REGULATED GENE 1; ONCOGENE C MYB; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL TIME; TUMOR DIFFERENTIATION; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CELL CYCLE PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UP-REGULATION; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42649098571     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.01.020     Document Type: Article

References (42)

1. 2+ compounds. Cancer Res. 58 (1998) 2182-2189
2. Shimono A., Okuda T., and Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech. Dev. 83 (1999) 39-52
3. Okuda T., and Kondoh H. Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem. Biophys. Res. Commun. 266 (1999) 208-215
4. Zhou R.H., Kokame K., Tsukamoto Y., Yutani C., Kato H., and Miyata T. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73 (2001) 86-97
5. Qu X., Zhai Y., Wei H., et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell Biochem. 229 (2002) 35-44
6. Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., and Lee S.W. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res. 58 (1998) 439-444
7. van Belzen N., Dinjens W.N., Diesveld M.P., et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab. Invest. 77 (1997) 85-92
8. Agarwala K.L., Kokame K., Kato H., and Miyata T. Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem. Biophys. Res. Commun. 272 (2000) 641-647
9. Kokame K., Kato H., and Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J. Biol. Chem. 271 (1996) 29659-29665
10. Masuda K., Ono M., Okamoto M., et al. Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. Int. J. Cancer 105 (2003) 6803-6810
11. Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., and Bosman F.T. Expression of NDRG1, a differentiation related gene, in human tissues. Histochem. Cell Biol. 118 (2002) 399-408
12. Wakisaka Y., Furuta A., Masuda K., Morikawa W., Kuwano M., and Iwaki T. Cellular distribution of NDRG1 protein in the rat kidney and brain during normal postnatal development. J. Histochem. Cytochem. 51 (2003) 1515-1525
13. Maruyama Y., Ono M., Kawahara A., et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogensis. Cancer Res. 66 (2006) 6233-6242
14. Bandyopadhyay S., Pai S.K., Hirota S., et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23 (2004) 5675-5681
15. Chua M.S., Sun H., Cheung S.T., et al. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod. Pathol. 20 (2007) 76-83
16. Kovacevic Z., and Richardson D.R. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27 (2006) 2355-2366
17. Zheng T., Holford T., Ma Z., et al. The continuing increase in adenocarcinoma of uterine cervix: a birth cohort phenomenon. Int. J. Epidemiol. 25 (1996) 252-258
18. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., and Parkin D. International trends in the incidence of cervical cancer: I, adenocarcinoma and adenosquamous cell carcinomas. Int. J. Cancer 75 (1998) 536-545
19. Smith H.O., Ti any M.F., Qualls C.R., and Key C.R. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol. Oncol. 78 (2000) 97-105
20. Visioli C.B., Zappa M., Ciatto S., Iossa A., and Crocetti E. Increasing trends of cervical adenocarcinoma incidence in Italy despite extensive screening programme, 1985-2000. Cancer Detect. Prev. 28 (2004) 461-464
21. Attanoos R., Nahar K., Bigrigg A., Roberts S., Newcombe R.G., and Ismail S.M. Primary adenocarcinoma of the cervix: a clinicopathologic study of the prognostic variables in 55 cases. Int. J. Gynecol. Cancer 5 (1995) 179-186
22. Quinn M.A. Adenocarcinoma of the cervix: are there arguments for a different treatment policy?. Curr. Opin. Obstet. Gynecol. 9 (1997) 21-24
23. Grisaru D., Covens A., Chapman B., et al. Does histology influence prognosis in patients with early-stage cervical adenocarcinoma?. Cancer 92 (2001) 2999-3004
24. Kim Y.B., Kim G.E., Pyo H.R., et al. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 822-829
25. Matsukuma K., Tsukamoto N., Kaku T., et al. Early adenocarcinoma of the uterine cervix: its histologic and immunohistologic study. Gynecol. Oncol. 35 (1989) 38-43
26. Jones M.W., Kounelis S., Papadaki H., et al. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus. Int. J. Gynecol. Pathol. 19 (2000) 110-117
27. Folkman J. Angiogenesis in cancer vascular rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
28. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
29. Kerbel R., and Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2 (2002) 727-739
30. West C.M., Cooper R.A., Loncaster J.A., Wilks D.P., and Bromley M. Tumor vascularity: a histological measure of angiogenesis and hypoxia. Cancer Res. 61 (2001) 2907-2910
31. Cooper R.A., Wilks D.P., Logue J.P., et al. High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin. Cancer Res. 4 (1998) 2795-2800
32. Kaku T., Hirakawa T., Kamura T., et al. Angiogenesis in adenocarcinoma of the uterine cervix. Cancer 83 (1998) 1384-1390
33. Bandyopadhyay S., Pai S.K., Gross S.C., Hirota S., Hosobe S., and Miura K. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 63 (2003) 1731-1736
34. Ulrix W., Swinnen J.V., Heyns W., and Verhoeven G. The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett. 455 (1999) 23-26
35. Caruso R.P., Levinson B., Melamed J., et al. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients. Clin. Cancer Res. 10 (2004) 222-227
36. Chin K.F., Greenman J., Gardiner E., Kumar H., Topping K., and Monson J. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. Br. J. Cancer 83 (2000) 1425-1431
37. Fine B.A., Valente P.T., Feinstein G.I., and Dey T. VEGF, fit-1, and KDR/fik-1 as prognostic indicators in endometrial carcinoma. Gynecol. Oncol. 76 (2000) 33-39
38. Seo Y., Baba H., Fukuda T., Takashima M., and Sugimachi K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with duatal pancreatic adenocarcinoma. Cancer 88 (2000) 2239-2245
39. Takahama M., Tsutsumi M., Tsujiuchi T., et al. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinoma. Clin. Cancer Res. 5 (1999) 2506-2510
40. Hirata K., Masuda K., Morikawa W., et al. N-myc downstream-regulated gene 1 expression in injured sciatic nerves. Glia 47 (2004) 325-334
41. Sugiki T., Murakami M., Taketomi Y., Kikuchi-Yanoshita R., and Kudo I. N-myc downregulated gene 1 is a phosphorylated protein in mast cells. Biol. Pharm. Bull. 27 (2004) 624-627
42. Kose S., Furuta M., Koike M., Yoneda Y., and Imamoto N. The 70-kDa heat shock cognate protein (hsc70) facilitates the nuclear export of the import receptors. J. Cell Biol. 171 (2005) 19-25